Eikon Therapeutics, Inc.
EIKN
$8.77
-$0.21-2.34%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 52.45% | 0.00% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 34.90% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 0.00% | -- | |||
| Total Current Assets | 51.76% | -- | |||
|
|
|||||
| Total Current Assets | 51.76% | -- | |||
| Net Property, Plant & Equipment | -2.02% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -30.03% | -- | |||
| Total Assets | 43.06% | -- | |||
|
|
|||||
| Total Accounts Payable | 781.79% | -- | |||
| Total Accrued Expenses | -33.84% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -2.87% | -- | |||
| Total Finance Division Other Current Liabilities | -25.55% | -- | |||
| Total Other Current Liabilities | -25.55% | -- | |||
| Total Current Liabilities | -18.08% | -- | |||
|
|
|||||
| Total Current Liabilities | -18.08% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -0.89% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 0.00% | -- | |||
| Total Liabilities | -3.89% | -- | |||
|
|
|||||
| Common Stock & APIC | 3,647.17% | -- | |||
| Retained Earnings | -9.01% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 162.65% | 0.00% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 0.00% | |||
|
|
|||||
| Total Common Equity | 162.65% | 0.00% | |||
| Total Preferred Equity | -- | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 94.97% | 0.00% | |||
|
|
|||||